{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:32:06Z","timestamp":1793496726343,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008043","name":"Zhejiang Institute of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008043","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2021YZ036017"],"award-info":[{"award-number":["2021YZ036017"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022963","name":"Key Research and Development Program of Zhejiang Province","doi-asserted-by":"publisher","award":["2024C03172"],"award-info":[{"award-number":["2024C03172"]}],"id":[{"id":"10.13039\/100022963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.aohep.2024.101773","type":"journal-article","created":{"date-parts":[[2024,12,12]],"date-time":"2024-12-12T11:48:21Z","timestamp":1734004101000},"page":"101773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1"],"prefix":"10.1016","volume":"30","author":[{"given":"Yinghao","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuangda","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aohep.2024.101773_bib0001","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"issue":"2","key":"10.1016\/j.aohep.2024.101773_bib0002","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/1078-0432.CCR-14-3296","article-title":"Molecular Pathogenesis and targeted therapies for intrahepatic cholangiocarcinoma","volume":"22","author":"Moeini","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.aohep.2024.101773_bib0003","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrgastro.2016.51","article-title":"Expert consensus document: cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)","volume":"13","author":"Banales","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.aohep.2024.101773_bib0004","article-title":"Gemcitabine-based chemotherapy for advanced biliary tract carcinomas","volume":"4","author":"Abdel-Rahman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.aohep.2024.101773_bib0005","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jhep.2021.04.004","article-title":"Medical therapies for intra-hepatic cholangiocarcinoma","volume":"75","author":"Vithayathil","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.aohep.2024.101773_bib0006","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.aohep.2024.101773_bib0007","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19102885","article-title":"The role of stroma in cholangiocarcinoma: the intriguing interplay between fibroblastic component, immune cell subsets and tumor epithelium","volume":"19","author":"Gentilini","year":"2018","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.aohep.2024.101773_bib0008","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.it.2015.02.004","article-title":"Macrophages and cancer: from mechanisms to therapeutic implications","volume":"36","author":"Ostuni","year":"2015","journal-title":"Trends Immunol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101773_bib0009","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.cell.2009.11.007","article-title":"Epithelial-mesenchymal transitions in development and disease","volume":"139","author":"Thiery","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.aohep.2024.101773_bib0010","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1146\/annurev-pathol-020117-043854","article-title":"Epithelial mesenchymal transition in tumor metastasis","volume":"13","author":"Mittal","year":"2018","journal-title":"Annu Rev Pathol"},{"issue":"2","key":"10.1016\/j.aohep.2024.101773_bib0011","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canlet.2014.05.008","article-title":"Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial-mesenchymal transition in hepatocellular carcinoma","volume":"352","author":"Fan","year":"2014","journal-title":"Cancer Lett"},{"issue":"1","key":"10.1016\/j.aohep.2024.101773_bib0012","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13046-021-02235-8","article-title":"Macrophages-aPKC(i)-CCL5 feedback loop modulates the progression and chemoresistance in cholangiocarcinoma","volume":"41","author":"Yang","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.aohep.2024.101773_bib0013","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/nrc1673","article-title":"Id family of helix-loop-helix proteins in cancer","volume":"5","author":"Perk","year":"2005","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"10.1016\/j.aohep.2024.101773_bib0014","doi-asserted-by":"crossref","first-page":"995","DOI":"10.7150\/ijms.42805","article-title":"Inhibitor of differentiation 1 (ID1) in cancer and cancer therapy","volume":"17","author":"Zhao","year":"2020","journal-title":"Int J Med Sci"},{"issue":"12","key":"10.1016\/j.aohep.2024.101773_bib0015","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1158\/1078-0432.CCR-10-3381","article-title":"Inhibitor of differentiation-1 as a novel prognostic factor in NSCLC patients with adenocarcinoma histology and its potential contribution to therapy resistance","volume":"17","author":"Ponz-Sarvise","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"5","key":"10.1016\/j.aohep.2024.101773_bib0016","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.3892\/ol.2017.5828","article-title":"siRNA-mediated knockdown of ID1 disrupts Nanog- and Oct-4-mediated cancer stem cell-likeness and resistance to chemotherapy in gastric cancer cells","volume":"13","author":"Li","year":"2017","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.aohep.2024.101773_bib0017","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2009.10.012","article-title":"ID1, inhibitor of differentiation, is a key protein mediating anti-tumor responses of gamma-tocotrienol in breast cancer cells","volume":"291","author":"Yap","year":"2010","journal-title":"Cancer Lett"},{"issue":"2","key":"10.1016\/j.aohep.2024.101773_bib0018","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2217\/fon.13.179","article-title":"Crizotinib inhibits migration and expression of ID1 in MET-positive lung cancer cells: implications for MET targeting in oncology","volume":"10","author":"Stutz","year":"2014","journal-title":"Future Oncol"},{"issue":"6","key":"10.1016\/j.aohep.2024.101773_bib0019","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.ccell.2016.05.005","article-title":"YAP\/TAZ at the roots of cancer","volume":"29","author":"Zanconato","year":"2016","journal-title":"Cancer Cell"},{"issue":"5","key":"10.1016\/j.aohep.2024.101773_bib0020","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.celrep.2018.10.001","article-title":"Comprehensive molecular characterization of the hippo signaling pathway in cancer","volume":"25","author":"Wang","year":"2018","journal-title":"Cell Rep"},{"issue":"12","key":"10.1016\/j.aohep.2024.101773_bib0021","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1038\/onc.2015.219","article-title":"YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage","volume":"35","author":"Ciamporcero","year":"2016","journal-title":"Oncogene"},{"key":"10.1016\/j.aohep.2024.101773_bib0022","article-title":"Mutations and copy number abnormalities of hippo pathway components in human cancers","volume":"9","author":"He","year":"2021","journal-title":"Front Cell Dev Biol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101773_bib0023","doi-asserted-by":"crossref","first-page":"e12633","DOI":"10.1111\/cpr.12633","article-title":"Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta\/SMAD signalling","volume":"52","author":"Dong","year":"2019","journal-title":"Cell Prolif"},{"issue":"595","key":"10.1016\/j.aohep.2024.101773_bib0024","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aav2041","article-title":"Reverse signaling by semaphorin 4C elicits SMAD1\/5- and ID1\/3-dependent invasive reprogramming in cancer cells","volume":"12","author":"Gurrapu","year":"2019","journal-title":"Sci Signal"},{"key":"10.1016\/j.aohep.2024.101773_bib0025","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.31756","article-title":"TGF-beta uses a novel mode of receptor activation to phosphorylate SMAD1\/5 and induce epithelial-to-mesenchymal transition","volume":"7","author":"Ramachandran","year":"2018","journal-title":"Elife"},{"issue":"35","key":"10.1016\/j.aohep.2024.101773_bib0026","doi-asserted-by":"crossref","first-page":"4792","DOI":"10.1038\/s41388-018-0316-y","article-title":"Mediator kinase CDK8\/CDK19 drives YAP1-dependent BMP4-induced EMT in cancer","volume":"37","author":"Serrao","year":"2018","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.aohep.2024.101773_bib0027","doi-asserted-by":"crossref","first-page":"6050","DOI":"10.1007\/s12010-022-04253-4","article-title":"The interaction between SMAD1 and YAP1 Is correlated with increased resistance of gastric cancer cells to cisplatin","volume":"195","author":"Chen","year":"2023","journal-title":"Appl Biochem Biotechnol"},{"issue":"5","key":"10.1016\/j.aohep.2024.101773_bib0028","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/bcpt.13042","article-title":"IL-6 triggers the migration and invasion of oestrogen receptor-negative breast cancer cells via regulation of hippo pathways","volume":"123","author":"Hou","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"11","key":"10.1016\/j.aohep.2024.101773_bib0029","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.aohep.2024.101773_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107158","article-title":"Oncostatin M: a mysterious cytokine in cancers","volume":"90","author":"Masjedi","year":"2021","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"10.1016\/j.aohep.2024.101773_bib0031","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001946","article-title":"Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3","volume":"9","author":"Zhou","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"1","key":"10.1016\/j.aohep.2024.101773_bib0032","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13046-020-01611-0","article-title":"Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways","volume":"39","author":"Yoshida","year":"2020","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"10.1016\/j.aohep.2024.101773_bib0033","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1158\/2159-8290.CD-19-0529","article-title":"ID1 mediates escape from TGFbeta tumor suppression in pancreatic cancer","volume":"10","author":"Huang","year":"2020","journal-title":"Cancer Discov"},{"issue":"16","key":"10.1016\/j.aohep.2024.101773_bib0034","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1158\/0008-5472.CAN-18-1357","article-title":"ID1 is critical for tumorigenesis and regulates chemoresistance in glioblastoma","volume":"79","author":"Sachdeva","year":"2019","journal-title":"Cancer Res"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268124005568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:32:32Z","timestamp":1777782752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268124005568"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S1665268124005568"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101773","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-associated macrophages contribute to cholangiocarcinoma progression and chemoresistance through activation of ID1","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2024.101773","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"101773"}}